HSR24-162: Treatment Patterns in Surgically Resected NSCLC Since the Introduction of Immuno-Oncology Agents

J Natl Compr Canc Netw. 2024 Apr 5;22(2.5):HSR24-162. doi: 10.6004/jnccn.2023.7166.NO ABSTRACTPMID:38580274 | DOI:10.6004/jnccn.2023.7166

Source: Journal of the National Comprehensive Cancer Network : JNCCN - April 5, 2024 Category: Cancer & Oncology Authors: Jhanelle E Gray Daniel Simmons Lu Zou Yahan Zhang Wale Oyebanji Tiernan Mulrooney Source Type: research